In CML blasts the BCR/ABL fusion protein activates the RNA binding protein hnRNP E2 that, by binding the 5′UTR of the CEBPα mRNA, inhibits its translation and myeloid differentiation. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.